Modulation by cytochrome P450-4A ω-hydroxylase enzymes of adrenergic vasoconstriction and response to reduced PO₂ in mesenteric resistance arteries of Dahl salt-sensitive rats

Microcirculation. 2010 Oct;17(7):525-35. doi: 10.1111/j.1549-8719.2010.00053.x.

Abstract

Objective: This study evaluated the contribution of the 20-HETE/cytochrome P450-4A ω-hydroxylase (CYP4A) system to the early development of salt-induced vascular changes in Dahl salt-sensitive (SS) rats.

Methods: CYP4A expression and 20-HETE production were evaluated and responses to norepinephrine, endothelin, and reduced PO₂ were determined by video microscopy in isolated mesenteric resistance arteries from SS rats fed high salt (HS; 4% NaCl) diet for three days vs. low salt (LS; 0.4% NaCl) controls.

Results: CYP4A enzyme inhibition with dibromododecenyl methylsulfimide (DDMS) selectively reduced norepinephrine sensitivity and restored impaired vasodilation in response to reduced PO₂ in SS rats fed HS diet. In the presence of DDMS, vasodilatation to reduced PO₂ was eliminated by indomethacin and unaffected by l-NAME in rats fed LS diet, and eliminated by l-NAME and unaffected by indomethacin in rats fed HS diet. The 20-HETE agonist WIT003 restored norepinephrine sensitivity in DDMS-treated arteries of HS-fed rats. HS diet increased vascular 20-HETE production and CYP4A protein levels by ∼24% and ∼31%, respectively, although these differences were not significant.

Conclusions: These findings support the hypothesis that the 20-HETE/CYP4A system modulates vessel responses to norepinephrine and vascular relaxation to reduced PO₂ in mesenteric resistance arteries of SS rats fed HS diet.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Amides / pharmacology
  • Animals
  • Cyclooxygenase Inhibitors / pharmacology
  • Cytochrome P-450 CYP4A / antagonists & inhibitors
  • Cytochrome P-450 CYP4A / metabolism*
  • Endothelin-1 / pharmacology
  • Enzyme Inhibitors / pharmacology
  • Hydroxyeicosatetraenoic Acids / agonists
  • Hydroxyeicosatetraenoic Acids / biosynthesis
  • Hydroxyeicosatetraenoic Acids / pharmacology
  • Hypoxia / physiopathology*
  • In Vitro Techniques
  • Indomethacin / pharmacology
  • Male
  • Mesenteric Arteries / drug effects
  • Mesenteric Arteries / physiopathology*
  • Microscopy, Video
  • NG-Nitroarginine Methyl Ester / pharmacology
  • Nitric Oxide Synthase / antagonists & inhibitors
  • Norepinephrine / pharmacology
  • Rats
  • Rats, Inbred Dahl
  • Sodium Chloride, Dietary / administration & dosage*
  • Sodium Chloride, Dietary / toxicity
  • Sulfones / pharmacology
  • Vascular Resistance / drug effects
  • Vascular Resistance / physiology
  • Vasoconstriction / drug effects
  • Vasoconstriction / physiology*

Substances

  • 20-hydroxyeicosa-5(Z),14(Z)-dienoic acid
  • Amides
  • Cyclooxygenase Inhibitors
  • Endothelin-1
  • Enzyme Inhibitors
  • Hydroxyeicosatetraenoic Acids
  • Sodium Chloride, Dietary
  • Sulfones
  • 20-hydroxy-5,8,11,14-eicosatetraenoic acid
  • DDMS
  • Nitric Oxide Synthase
  • Cytochrome P-450 CYP4A
  • NG-Nitroarginine Methyl Ester
  • Norepinephrine
  • Indomethacin